로딩 중…
지수 로딩 중…
Avalyn Pharma Inc. Common Stock
AVLN· NASDAQ· Health Care
$25.71-0.12%
2026-10-29
Financials
Valuation Metrics
Avalyn Pharma Inc. Common Stock's Market Cap is $1.14B. Ranked #2342 of 3,115 in US market (top 75%), #942 of 1,472 on NASDAQ (top 64%) by Market Cap.
Investment Metrics(as of 2026-10-29)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.14B | US#2,342/3,115 |
| Revenue | $0.00 | US#2,861/3,115 |
| Net Income | $-85M | US—/3,115 |
| Total Assets | $149M | US#3,022/3,115 |
| Net Assets | $-239M | US#2,988/3,115 |
| Value | ||
| FCF Yield | -7.18% | US—/3,115 |
| Profitability | ||
| ROA | -57.23% | US#3,008/3,115 |
| Financial Health | ||
| Total Debt | $2M | US#2,953/3,115 |
| FCF | $-82M | US#2,596/3,115 |
| Cash | $52M | US#2,553/3,115 |
| Current Ratio | 10.19x | US#244/3,115 |
| Performance | ||
| 1M Return | -5.13% | US#2,528/3,115 |
| From 52W High | -36.00% | US#2,228/3,115 |
| 1Y MDD | -40.56% | US#1,957/3,115 |
| Trading | ||
| Volume | 589,138 shares | US#1,419/3,115 |
| Trading Value | $15M | US#1,700/3,115 |
| Per Share | ||
| EPS | $-1.92 | US—/3,115 |
| BPS | $-5.38 | US—/3,115 |